MIPS Project Detail:
Company
Company Description:
Medcura (formerly gel-e Inc.), a privately held, clinical-stage medical device company, develops a broad range of hemostatic and wound treatment products, including bandages for the treatment of routine cuts and scrapes, foams and putties for traumatic and military injuries, and surgical gels and powders.
MIPS Project
LifeCoat: Absorbable Hemostatic Powder
Project #
7328
|
MIPS Round
73
|
Starting Date:
Feb 2024
Medcura simply would not be alive and thriving without the support of MIPS. Our 2008 MIPS grant was the first substantial research grant that we received, and that funding has created a platform for our company to raise over $1.7 million in non-dilutive funding and reach a first regulatory milestone. Medcura hopes to continue to serve as an example of a real-world manifestation of the vision for the MIPS program.
-
Matthew Dowling, Founder and CSO, Medcura
Results:
-
Principal Investigator:
Srinivasa
Raghavan
,
,
Professor, Department of Chemical and Biomolecular Engineering
Project Manager:
Matthew
Dowling
,
,
Founder, Chief Scientific Officer
Technologies:
Biotechnology / Genetic Engineering
Chemical Engineering / Chemistry
Materials Science